Analysis for TDY
$619.91
+11.01
(+1.81%)
- π Growth β 26/30
- π° Profitability β 18/20
- π¦ Financial Health β 19/20
- π΅ Valuation β 12/20
- β οΈ Risk β 4/10
Overall Score: 81/100
Summary:
π Growth & Financial Trajectory
From 2024 Q1 to 2027 Q2, Revenues rose from about $1.45B to $1.66Bβa roughly 14β15% gainβwhile Net Income climbed from $178.5M to $251.7M (peaking at $275.6M in 2026 Q4). The path shows a mid-period dip early in 2024β25, but a clear upcycle with higher earnings in successive quarters and improving profitability.
π° Margins & Cash Flow
- Gross Margin sits in the midβ40s percent (Gross Profit $0.58β$0.74B on Revenues $1.35β$1.66B).
- Operating Margin runs in the high teens to about 20%, with Operating Income tracking revenue growth.
- Cash Flow: operating cash flow is generally positive across quarters, with investing outlays and financing activity driving variability in total net cash flow.
π‘οΈ Balance Sheet & Liquidity
Balance sheet strength is solid: Assets β $15B, Equity β $9β11B, Liabilities β $4.7B in the recent period. Current Assets exceed Current Liabilities, yielding a healthy liquidity cushion. Debt levels are moderate (Longβterm Debt around $2β3B) relative to equity, supporting resilience.
β οΈ Key Drivers & Risks
- Drivers: Defense/aerospace and industrial instrumentation demand; sustained R&D; automation adoption.
- Risks: cyclicality in government/private spend; valuation sensitivity to earnings swings; interest-rate and supply-chain exposure.
π Key Financial Fundamentals
Valuation Multiples
Market Cap
$27.86B
P/E Ratio
28.58
Forward P/E
24.34
P/S Ratio
4.37
P/B Ratio
2.72
EV / EBITDA
19.99
Profitability & Returns
Gross Margin
43.34%
Operating Margin
19.68%
Net Margin
15.29%
ROE
9.13%
ROIC
7.47%
Financial Health & Liquidity
Current Ratio
2.18
Quick Ratio
1.16
Financial Scale & Cash Flow
Revenue
$6.37B
Net Income
$0.97B
FCF Yield
4.10%
Free Cash Flow
$1.14B
Total Debt To Equity
0.19